Company intelligence / Profile preview

Mimio Health

San Francisco, California, United Statesmimiohealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Mimio's formulation has been shown to extend the lifespan of model organisms by 96%, enhance cellular antioxidant capacity by up to 3x, and reduce inflammation by 10x[1][3]

Therapeutic areas: Other
Modalities: Dietary supplementsfasting mimetics
Industry: Food & Nutrition

Drug pipeline

1 asset

mimio

Commercial

Indications: Metabolic disorders, Aging

Beyond the preview

Go deeper on Mimio Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mimio Health.

Explore the full profile